新闻
2023-11-20
先博生物通用型CAR-NK疗法申报临床,针对系统性红斑狼疮!
细胞疗法临床申请免疫疗法
2023-11-20
一线治疗胃癌!默沙东重磅PD-1抑制剂再获FDA批准
临床结果上市批准加速审批
2023-11-20
复星医药新一代重组溶瘤腺病毒产品获批临床
临床申请免疫疗法
2023-11-17
抗体药物偶联物申请上市
2023-11-17
Polaris Group Initiates Rolling Submission of Biologic License Application (BLA) for ADI-PEG 20 with U.S. FDA to Treat Malignant Pleural Mesothelioma
临床结果优先审批
2023-11-17
Praxis Precision Medicines Receives PRIME Designation from the EMA for elsunersen (PRAX-222) for Treatment of SCN2A Gain of Function Developmental Epilepsies
孤儿药
2023-11-17
康威生物肿瘤免疫新药在美国获批临床
免疫疗法临床申请临床1期
2023-11-17
Palvella Therapeutics Announces U.S. FDA Breakthrough Therapy Designation Granted to QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Microcystic Lymphatic Malformations
孤儿药快速通道突破性疗法临床结果
2023-11-17
刚刚!亿帆医药宣布「艾贝格司亭α」在美国获批上市
上市批准临床3期引进/卖出
2023-11-17
百时美施贵宝:FDA批准Repotrectinib上市
上市批准并购抗体药物偶联物引进/卖出